Abstract
Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK). This kinase cascade controls the proliferation and differentiation of different cell types1,2. Here we describe a Raf-1-interacting protein, isolated using a yeast two-hybrid screen. This protein inhibits the phosphorylation and activation of MEK by Raf-1 and is designated RKIP (Raf kinase inhibitor protein). In vitro, RKIP binds to Raf-1, MEK and ERK, but not to Ras. RKIP co-immunoprecipitates with Raf-1 and MEK from cell lysates and colocalizes with Raf-1 when examined by confocal microscopy. RKIP is not a substrate for Raf-1 or MEK, but competitively disrupts the interaction between these kinases. RKIP overexpression interferes with the activation of MEK and ERK, induction of AP-1-dependent reporter genes and transformation elicited by an oncogenically activated Raf-1 kinase. Downregulation of endogenous RKIP by expression of antisense RNA or antibody microinjection induces the activation of MEK-, ERK- and AP-1-dependent transcription. RKIP represents a new class of protein-kinase-inhibitor protein that regulates the activity of the Raf/MEK/ERK module.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Ferrell, J. E. Jr MAP kinases in mitogenesis and development. Curr. Top. Dev. Biol. 33, 1–60 (1996).
Morrison,D. K. & Cutler,R. E. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9, 174–179 (1997).
Moodie,S. A., Willumsen,B. M., Weber,M. J. & Wolfman,A. Complexes of Ras/GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260, 1658–1661 (1993).
Schaeffer,H. J. et al. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668–1671 (1998).
Bruder,J. T., Heidecker,G. & Rapp,U. R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6, 545–556 (1992).
Li,S. et al. Regulation of Raf-1 kinase activity by the I4-3-3 family of proteins. EMBO J. 14, 685–696 (1995).
Schoentgen,F. & Jolles,P. From structure to function: possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site. FEBS Lett. 369, 22–26 (1995).
Kortenjann,M. Thomae,O. & Shaw,P. E. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol. Cell. Biol. 14, 4815–4824 (1994).
Rapp,U. R., Troppmair,J., Beck,T. & Birrer,M. J. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene 9, 3493–3498 (1994).
Kolch,W. et al. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum. Oncogene 8, 361–370 (1993).
Catling,A. D., Schaeffer,H. J., Reuter,C. W., Reddy,G. R. & Weber,M. J. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function. Mol. Cell. Biol. 15, 5214–5225 (1995).
Kolch,W. et al. Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding. Oncogene 13, 1305–1314 (1996).
Hallberg,B., Rayter,S. I. & Downward,J. Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J. Biol. Chem. 269, 3913–3916 (1994).
Ferrell, J. E. Jr Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem. Sci. 21, 460–466 (1996).
Tombes,R. M. et al. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem. J. 330, 1451–1460 (1998).
Marshall,C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179–185 (1995).
Sewing,A., Wiseman,B., Lloyd,A. C. & Land,H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5588–5597 (1997).
Woods,D. et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5598–5611 (1997).
Grandy,D. K. et al. Purificaton, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. Mol. Endocrinol. 4, 1370–1376 (1990).
Gjorup,O. V., Rose,P. E., Holman,P. S., Bockus,B. J. & Schaffhausen,B. S. Protein domains connect cell cycle stimulation directly to initiation of DNA replication. Proc. Natl Acad. Sci. USA 91, 12125–12129 (1994).
Häfner,S. et al. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14, 6696–6703 (1994).
Guan,K. L. & Dixon,J. E. Eucaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192, 262–267 (1991).
Mischak,H. et al. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16, 5409–5418 (1996).
Lavbinsky,R. M. et al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl Acad. Sci. USA 95, 2920–2925 (1998).
Rose,D. W., McCabe,G., Feramisco,J. R. & Adler,M. Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis. J. Cell Biol. 119, 1405–1411 (1992).
Minden,A. et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266, 1719–1723 (1994).
Acknowledgements
We thank M. Karin, M. Weber, F. Hofer, P. Shaw, M. Baccarini and B. Schaffhausen for various expression plasmids; D. K. Grandy for the full-length rat cDNA homologue of RKIP; and L. Black for help with microinjections. We appreciate critical reading and helpful comments by members of the Beatson laboratories. This work was in part supported by grants of the AICR, DFG and the Sanders Stiftung to W.K. and H.M. and by an NIH grant to J.M.S.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yeung, K., Seitz, T., Li, S. et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173–177 (1999). https://doi.org/10.1038/43686
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/43686
This article is cited by
-
A novel single nucleotide mutation of TFL1 alters the plant architecture of Gossypium arboreum through changing the pre-mRNA splicing
Plant Cell Reports (2024)
-
The mechanism of ferroptosis and its related diseases
Molecular Biomedicine (2023)
-
Binding of berberine to PEBP1 synergizes with sorafenib to induce the ferroptosis of hepatic stellate cells
Amino Acids (2023)
-
Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma
BMC Medical Genomics (2022)
-
Reduction of glutamatergic activity through cholinergic dysfunction in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice
Scientific Reports (2022)